The - A162G polymorphism of the PON1 gene and the risk of sporadic amyotrophic lateral sclerosis

Neurologia i Neurochirurgia Polska

Volumn 44, Issue 3, 2010, Pages 246-250

  Zawiślak, Dorota ^a   Ostrowska, Monika ^a   Golenia, Aleksandra ^a   Marona, Monika ^a   Tomik, Barbara ^a   Wołkow, Paweł ^a   Gryz Kurek, Elzbieta ^a   Szczudlik, Andrzej ^a   Słowik, Agnieszka ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Amyotrophic lateral sclerosis; Polymorphism; PON1

Indexed keywords

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CONTROLLED STUDY; FEMALE; GENE; GENE FREQUENCY; GENETIC RISK; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PON1 GENE; PON2 GENE; PROMOTER REGION; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 77954731831     PISSN: 00283843     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3843(14)60038-4     Document Type: Article

References (22)

1. Rowland L.P., Shneider N.A. Amyotrophic lateral sclerosis. N Engl J Med 2001; 344: 1688-1700.
2. Strong M.J. The basic aspects of therapeutics in amyotrophic lateral sclerosis. Pharmacol Ther 2003; 98: 379-414. (Pubitemid 36644160)
3. Saeed M., Siddique N., Hung W.Y., et al. Paraoxonase cluster polymorphisms are associated with sporadic ALS. Neurology 2006; 67: 771-776. (Pubitemid 44394187)
4. Haley R.W. Excess incidence of ALS in young Gulf War veterans. Neurology 2003; 61: 750-756.
5. Li H.L., Liu D.P., Liang C.C. Paraoxonase gene polymorphisms, oxidative stress, and diseases. J Mol Med 2003; 81: 766-779. (Pubitemid 38058159)
6. Cronin S., Greenway M.J., Prehn J.H., et al. Paraoxonase promoter and intronic variants modify risk of sporadic amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 2007; 78: 984-986. (Pubitemid 47310838)
7. Brophy V.H., Jampsa R.L., Clendenning J.B., et al. Effects of 5′ regulatory-region polymorphisms on paraoxonase-gene (PON1) expression. Am J Hum Genet 2001; 68: 1428-1436.
8. Brophy V.H., Hastings M.D., Clendenning J.B., et al. Polymorphisms in the human paraoxonase (PON1) promoter. Pharmacogenetics 2001; 11: 77-84.
9. Erlich P.M., Lunetta K.L., Cupples L.A., et al. Polymorphisms in the PON gene cluster are associated with Alzheimer disease. Hum Mol Genet 2006; 15: 77-85.
10. Slowik A., Tomik B., Wolkow P.P., et al. Paraoxonase gene polymorphisms and sporadic ALS. Neurology 2006; 67: 766-770. (Pubitemid 44394186)
11. Valdmanis P.N., Kabashi E., Dyck A., et al. Association of paraoxonase gene cluster polymorphisms with ALS in France, Quebec, and Sweden. Neurology 2008; 71: 514-520.
12. Landers J.E., Shi L., Cho T.J., et al. A common haplotype within the PON1 promoter region is associated with sporadic ALS. Amyotroph Lateral Scler 2008; 9: 306-314.
13. Wills A.M., Landers J.E., Zhang H., et al. Paraoxonase 1 (PON1) organophosphate hydrolysis is not reduced in ALS. Neurology 2008; 70: 929-934. (Pubitemid 351430741)
14. Morahan J.M., Yu B., Trent R.J., et al. A gene-environment study of the paraoxonase 1 gene and pesticides in amyotrophic lateral sclerosis. Neurotoxicology 2007; 28: 532-540. (Pubitemid 46843229)
15. Kasperaviciute D., Weale M.E., Shianna K.V., et al. Large-scale pathways-based association study in amyotrophic lateral sclerosis. Brain 2007; 130: 2292-2301.
16. Wills A.M., Cronin S., Slowik A., et al. A large-scale international meta-analysis of paraoxonase gene polymorphisms in sporadic ALS. Neurology 2009; 73: 16-24.
17. Brooks B.R., Miller R.G., Swash M., et al. El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000; 1: 293-299.
18. Wijesekera L.C., Leigh P.N. Amyotrophic lateral sclerosis. Orphanet J Rare Dis 2009; 4: 3.
19. Chiò A., Benzi G., Dossena M., et al. Severely increased risk of amyotrophic lateral sclerosis among Italian professional football players. Brain 2005; 128: 472-476. (Pubitemid 40380183)
20. Moulard B., Sefiani A., Laamri A., et al. Apolipoprotein E genotyping in sporadic amyotrophic lateral sclerosis: evidence for a major influence on the clinical presentation and prognosis. J Neurol Sci 1996; 139 (Suppl): 34-37.
21. al-Chalabi A., Enayat Z.E., Bakker M.C., et al. Association of apolipoprotein E epsilon 4 allele with bulbar-onset motor neuron disease. Lancet 1996; 347: 159-160.
22. Dunckley T., Huentelman M.J., Craig D.W., et al. Whole-genome analysis of sporadic amyotrophic lateral sclerosis. N Engl J Med 2007; 357: 775-788.